Terms: = Germ cell tumor AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG
16 results:
1. DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ.
Liu L; Zhu Z; Li X; Zheng Y
SLAS Discov; 2023 Jan; 28(1):19-28. PubMed ID: 36067936
[TBL] [Abstract] [Full Text] [Related]
2. Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.
Flies CM; van Leuken KH; Ten Voorde M; Verhoeff JJC; De Vos FYF; Seute T; Robe PA; Witkamp TD; Hendrikse J; Dankbaar JW; Snijders TJ
Neurology; 2022 Jul; 99(1):e77-e88. PubMed ID: 35437259
[TBL] [Abstract] [Full Text] [Related]
3. Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors.
Terziev R; Psimaras D; Marie Y; Feuvret L; Berzero G; Jacob J; Dehais C; Bompaire F; Mueller W; Kinnersley B; Delattre JY; Idbaih A; Hoang-Xuan K; Sanson M; Ricard D
Sci Rep; 2021 May; 11(1):10176. PubMed ID: 33986314
[TBL] [Abstract] [Full Text] [Related]
4. The Impact of PPARD and pparg Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract] [Full Text] [Related]
5. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
[No Abstract] [Full Text] [Related]
6. Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.
Wang Q; Cai J; Fang C; Yang C; Zhou J; Tan Y; Wang Y; Li Y; Meng X; Zhao K; Yi K; Zhang S; Zhang J; Jiang C; Zhang J; Kang C
Theranostics; 2018; 8(17):4733-4749. PubMed ID: 30279734
[No Abstract] [Full Text] [Related]
7. PPARγ Contributes to Immunity Induced by Cancer cell Vaccines That Secrete GM-CSF.
Goyal G; Wong K; Nirschl CJ; Souders N; Neuberg D; Anandasabapathy N; Dranoff G
Cancer Immunol Res; 2018 Jun; 6(6):723-732. PubMed ID: 29669721
[TBL] [Abstract] [Full Text] [Related]
8. Activation of Peroxisome Proliferator-Activated Receptor Gamma and Disruption of Progesterone Synthesis of 2-Ethylhexyl Diphenyl Phosphate in Human Placental Choriocarcinoma cells: Comparison with Triphenyl Phosphate.
Hu W; Gao F; Zhang H; Hiromori Y; Arakawa S; Nagase H; Nakanishi T; Hu J
Environ Sci Technol; 2017 Apr; 51(7):4061-4068. PubMed ID: 28282128
[TBL] [Abstract] [Full Text] [Related]
9. Identification of Unique, Heterozygous germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.
Buryk MA; Picarsic JL; Creary SE; Shaw PH; Simons JP; Deutsch M; Monaco SE; Nikiforov YE; Witchel SF
Pediatr Dev Pathol; 2015; 18(4):318-23. PubMed ID: 25751324
[TBL] [Abstract] [Full Text] [Related]
10. C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma.
Salcher S; Hagenbuchner J; Geiger K; Seiter MA; Rainer J; Kofler R; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
Mol Cancer; 2014 Sep; 13():224. PubMed ID: 25261981
[TBL] [Abstract] [Full Text] [Related]
11. Severe insulin resistance and hypertriglyceridemia after childhood total body irradiation.
Mayson SE; Parker VE; Schutta MH; Semple RK; Rickels MR
Endocr Pract; 2013; 19(1):51-8. PubMed ID: 23186952
[TBL] [Abstract] [Full Text] [Related]
12. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.
Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG
Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108
[TBL] [Abstract] [Full Text] [Related]
13. A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia.
Capaccio D; Ciccodicola A; Sabatino L; Casamassimi A; Pancione M; Fucci A; Febbraro A; Merlino A; Graziano G; Colantuoni V
Biochim Biophys Acta; 2010 Jun; 1802(6):572-81. PubMed ID: 20123124
[TBL] [Abstract] [Full Text] [Related]
14. Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk.
Mössner R; Meyer P; Jankowski F; König IR; Krüger U; Kammerer S; Westphal G; Boettger MB; Berking C; Schmitt C; Brockmöller J; Ziegler A; Stapelmann H; Kaiser R; Volkenandt M; Reich K
Cancer Lett; 2007 Feb; 246(1-2):218-23. PubMed ID: 16713673
[TBL] [Abstract] [Full Text] [Related]
15. An analysis of 8305 cases of carcinoid tumors.
Modlin IM; Sandor A
Cancer; 1997 Feb; 79(4):813-29. PubMed ID: 9024720
[TBL] [Abstract] [Full Text] [Related]
16. Knowledge of malignant melanoma and how it relates to clinical practice among nurse practitioners and dermatology and oncology nurses.
Maguire-Eisen M; Frost C
Cancer Nurs; 1994 Dec; 17(6):457-63. PubMed ID: 7820823
[TBL] [Abstract] [Full Text] [Related]
